TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 2 | -3 | 13 | -6 | -46 | -43 | -14 |
| S | %wins | 0 | 100 | 0 | 100 | 100 | 100 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/20/15 17:48 | 11/20/15 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Debrabandere Lode | MD | O | P,CEO | M.d | 257 | 6.84 | 5 | 38 | New | 38 | D | -29 | -19 | -41 | -39 | -37 | -38 | -26 | -24 | -5 | -3 | 1 | -32 | -53 | -39 |
5/18/09 07:36 | 5/14/09 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Debrabandere Lode | MD | O | SVP | M.d | 257 | 6.84 | 2 | 38 | 0 | D | -3 | -11 | -28 | -39 | -10 | -2 | -3 | -5 | 2 | -3 | 13 | -6 | -46 | -43 | |
5/18/09 07:36 | 5/14/09 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Debrabandere Lode | MD | O | SVP | S.d | -468 | 12.49 | 2 | -38 | -100 | 0 | D | -3 | -11 | -28 | -39 | -10 | -2 | -3 | -5 | 2 | -3 | 13 | -6 | -46 | -43 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |